However, no reports in the literature have documented the effect of calcium channel blockage by verapamil on Cx43 protein; therefore, study on Cx43, a new therapeutic target against cardiac arrhythmias, may provide new insight for the understanding of calcium channel blockage. This evidence concerns the gene GJA1 and cardiac arrhythmia.